Dendreon: Targeting Cancer, Transforming Lives
 Search
 

    Print Print page     Email Email page

SITE MAP

About Dendreon
  • Leadership Team
    • Mitchell H. Gold, M.D.
    • David L. Urdal, Ph.D.
    • Rick Hamm
    • Gregory T. Schiffman
    • Mark Frohlich, M.D.
  • Mission and Values
    • Letter from CEO
  • Contact Us
  • Directions
Therapeutic Approaches
  • Active Cellular Immunotherapy
  • Small Molecules
  • Scientific Publications
Pipeline
  • Sipuleucel-T
  • Lapuleucel-T
  • TRPM8
  • Preclinical Programs
  • Manufacturing
Patient Resources
  • Clinical Trials
    • Trial Sites
  • Patient Information
Newsroom
  • Calendar of Events
  • Glossary
  • Email Alerts
Investors
  • Governance
  • Stock Quote
  • Press Releases
  • Webcasts & Presentations
  • SEC Filings
  • Analyst Coverage
  • Annual Reports
  • Information Requests
  • Email Alerts
Careers
  • Career Opportunities
  • Working at Dendreon
  • Your Benefits
  • Dendreon in the Community
Privacy Policy  |  Legal Notice
© 2008 Dendreon Corporation. All Rights Reserved.
Home   |   Site Map   |   Contact Us